Tenet Healthcare Overview
Tenet Healthcare Target Price
Where could THC trade next? Consensus target price: $270.
Get informed when a big investor buys or sells
+ FollowShare Price
$270.21
Average Target Price
$271.84
0.6% upside
0.6% upside19 analysts in the last 4 months
High: $308 | Low: $210
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-14 | Raymond James | $285 | 5.5% upside |  |
| 2026-08-10 | Mizuho Securities | $290 | 7.3% upside | |
| 2026-08-03 | Wells FargoStephen Baxter | $281 | 4% upside | |
| 2026-07-28 | Goldman SachsScott Fidel | $305 | 12.9% upside | |
| 2026-07-28 | Truist FinancialDavid MacDonald | $290 | 7.3% upside | |
| 2026-07-28 | Robert W. BairdMichael Ha | $280 | 3.6% upside | |
| 2026-07-27 | Stephens | $285 | 5.5% upside | |
| 2026-07-27 | UBS | $308 | 14% upside | |
| 2026-07-27 | Piper Sandler | $308 | 14% upside | |
| 2026-07-27 | Morgan Stanley | $274 | 1.4% upside | |
| 2026-07-27 | Raymond JamesSarah James | $270 |  0.1% downside | |
| 2026-07-27 | RBC Capital | $283 | 4.7% upside | |
| 2026-07-24 | Barclays | $271 | 0.3% upside | |
| 2026-07-20 | Guggenheim | $242 | 10.4% downside | |
| 2026-07-13 | Wells FargoStephen Baxter | $231 | 14.5% downside | |
| 2026-05-05 | Robert W. Baird | $210 | 22.3% downside | |
| 2026-05-05 | BarclaysAndrew Mok | $238 | 11.9% downside | |
| 2026-05-04 | StephensScott Fidel | $260 | 3.8% downside | |
| 2026-05-01 | Morgan Stanley | $254 | 6% downside | |
| 2026-03-12 | GuggenheimJason Cassorla | $283 | 4.7% upside | |
| 2026-02-17 | Truist Financial | $270 | 0.1% downside | |
| 2026-02-16 | Wells FargoStephen Baxter | $265 | 1.9% downside | |
| 2026-02-13 | Guggenheim | $271 | 0.3% upside | |
| 2026-02-13 | BarclaysAndrew Mok | $257 | 4.9% downside | |
| 2026-02-12 | UBS | $288 | 6.6% upside | |
| 2026-02-12 | Morgan Stanley | $260 | 3.8% downside | |
| 2026-02-12 | RBC Capital | $277 | 2.5% upside | |
| 2026-02-12 | KeyBancMatthew Gillmor | $250 | 7.5% downside | |
| 2026-02-03 | RBC CapitalBen Hendrix | $253 | 6.4% downside | |
| 2026-01-07 | Wells Fargo | $229 | 15.3% downside | |
| 2025-12-18 | Morgan StanleyCraig Hettenbach | $247 | 8.6% downside | |
| 2025-12-02 | Guggenheim | $257 | 4.9% downside | |
| 2025-11-21 | BarclaysAndrew Mok | $240 | 11.2% downside | |
| 2025-11-03 | Truist Financial | $240 | 11.2% downside | |
| 2025-10-30 | RBC Capital | $252 | 6.7% downside | |
| 2025-10-29 | Raymond JamesSarah James | $245 | 9.3% downside | |
| 2025-10-29 | UBS | $260 | 3.8% downside | |
| 2025-10-29 | Morgan Stanley | $232 | 14.1% downside | |
| 2025-10-29 | Guggenheim | $238 | 11.9% downside | |
| 2025-10-17 | Mizuho SecuritiesAnn Hynes | $225 | 16.7% downside | |
| 2025-10-14 | Truist FinancialDavid MacDonald | $225 | 16.7% downside | |
| 2025-10-14 | Goldman SachsScott Fidel | $224 | 17.1% downside | |
| 2025-10-08 | KeyBancMatthew Gillmor | $225 | 16.7% downside | |
| 2025-10-07 | Wells FargoStephen Baxter | $238 | 11.9% downside | |
| 2025-09-18 | Barclays | $229 | 15.3% downside | |
| 2025-07-16 | Truist FinancialDavid MacDonald | $205 | 24.1% downside | |
| 2025-03-26 | Morgan Stanley | $165 | 38.9% downside | |
| 2025-01-07 | KeyBancMatthew Gillmor | $185 | 31.5% downside | |
| 2024-12-16 | Goldman SachsJamie Perse | $140 | 48.2% downside | |
| 2024-10-29 | Wolfe ResearchJustin Lake | $178 | 34.1% downside | |